ENGLEWOOD, Colo., March 6,
2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an
innovative medical technology company specializing in the
manufacture and sale of non-invasive medical devices for pain
management, rehabilitation, and patient monitoring, today announced
that the company will postpone the release of its fourth quarter
and full year financial results and conference call initially
scheduled for Monday, March 6, 2023
at 4:15 p.m. ET.
The company will announce its fourth quarter and full year 2022
financial results and conference call schedule in a future press
release to allow additional time to complete its year-end closing
procedures.
About Zynex, Inc.
Zynex, founded in 1996,
develops, manufacturers, markets, and sells medical devices used
for pain management and rehabilitation as well as non-invasive
fluid, sepsis and laser-based pulse oximetry
monitoring systems for use in hospitals. For additional
information, please visit: www.zynex.com
Contact: Zynex, Inc. (800) 495-6670
Investor Relations Contact:
Gilmartin Group
Investor Relations Counsel
ir@zynex.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zynex-inc-to-postpone-fourth-quarter-and-full-year-2022-financial-results-release-and-conference-call-301763794.html
SOURCE Zynex